Influence of gastrointestinal hormones on the development of obesity and non-alcoholic fatty liver disease in children

Authors

  • Parkhomenko L. K. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
  • Strashok L. A. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
  • Khomenko M. A. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2019.3.17

Keywords:

gastrointestinal hormones, obesity, non-alcoholic fatty liver disease, children

Abstract

Obesity is becoming a global epidemic among children, and the social significance of this problem is determined by the threat of disability of young patients, reducing life expectancy and the development of severe comorbidities. As a result of the increasing number of studies on energy homeostasis, it has been suggested that obesity is a multifactorial and more complex disease than previously thought. In recent years, the attention of researchers is increasingly attracted to the study of intestinal microbiota and its impact on human health, due to the development of new technologies and methods of studying the microbiome. Recent studies have shown that there is a mutual influence of the brain and intestines on each other, and there is increasing evidence that confirms the role of this complex relationship in the regulation of hunger, satiation and energy balance. It is proved that there is a direct impact on these processes of intestinal microbiota, and mediated through its intervention in the synthesis and metabolism of hormones and biologically active compounds of the digestive system. Today it is known that the gastrointestinal tract is one of the human organs where the most hormones are synthesized. At the present stage of development of science, it is known that there are more than 30 gastrointestinal hormones and biologically active substances that regulate the processes of digestion and participate in the regulation of general homeostasis. The most important role in the development of obesity and non-alcoholic fatty liver disease belongs to hormones such as ghrelin, peptide YY and glucagon-like peptide 1. The literature review presents current data that demonstrate the role of gastrointestinal hormones in the formation and development of obesity and non-alcoholic fatty liver disease in children as well as data of own research.

References

WHO. Commission on Ending Childhood Obesity. Facts and figures on childhood obesity, Geneva, 2017.

Birerdinc A, Stoddard S, Younossi Z. Cur Gastroenterol Reports 2018; 20(6): 24. doi: https://doi.org/10.1007/s11894-018-0629-6.

Anderson EL, et al. PloS one 2015; 10(10): e0140908.

Reinehr T, Roth CL. Endocrine 2015; 49(1): 35-50. doi: https://doi.org/10.1007/s12020-014-0518-1.

Koukias N, Buzzetti E, Tsochatzis E. Minerva Endocrinol 2017; 42(2): 184-194. doi: https://doi.org/10.23736/S0391-1977.16.02567-0.

Roth CL, Doyle RP. Endocrine Development 2017; 32: 100-123. doi: https://doi.org/10.1159/000475734.

Murugesan S, et al. Eur J Clin Microbiol Infect Dis 2018; 37(4): 621-625.

Jenkins T, et al. Nutrients 2016; 8(1): 56. doi: https://doi.org/10.3390/nu8010056.

Steinert RE, et al. Physiol Rev 2016; 97(1): 411-463. doi: https://doi.org/10.1152/physrev.00031.2014.

Gibbons C, et al. J Clin Endocrinol Metab 2013; 98(5): 847-855. doi: https://doi.org/10.1210/jc.2012-3835.

Roth CL, et al. J Pediatr Endocrinol Metab 2010; 23(12): 1299-1309.

Roth CL, et al. J Clin Endocrinol Metab 2005; 90(12): 6386-6391.

Reinehr T, et al. J Pediatr Endocrinol Metab 2010; 23(1-2): 101-108.

Breton J, et al. Cell Metab 2016; 23(2): 324-334. doi: https://doi.org/10.1016/j.cmet.2015.10.017.

Sumithran P, et al. New Engl J Med 2011; 365(17): 1597-1604. doi: https://doi.org/10.1056/NEJMoa1105816.

Jensen DE, et al. Pediatr Obes 2015; 10(5): 380-387.

Vos RC, et al. ISRN Endocrinol 2011; 2011: 353-359.

Alisi A, et al. Aliment Pharmacol Ther 2014; 39(11): 1276-1285.

Chalasani N, et al. Hepatology 2018; 67(1): 328-357. doi: https://doi.org/10.1002/hep.29367.

Armstrong MJ, et al. The Lancet 2016; 387(10019): 679-690. doi: https://doi.org/10.1016/S0140-67361500803-X.

Danne T, et al. J Pediatr 2017;181: 146-153. doi: https://doi.org/10.1016/j.jpeds.2016.10.076.

Zanchi D, et al. Neurosci Biobehav Rev 2017; 80: 457-475. doi: https://doi.org/10.1016/j.neubiorev.2017.06.013.

Arslan N, Sayin O, Tokgoz Y. J Endocrinol Invest 2014; 37(11): 1091-1097.

Balagopal P, et al. Obesity 2010; 18(9): 1747-1753.

Delhanty PJ, et al. Endocrine 2013; 43(2): 247-248. doi: https://doi.org/10.1007/s12020-012-9800-2.

Beglinger S, et al. Obesity 2014; 22(9): 2047-2052.

Sun EW, et al. Front Endocrinol 2018; 9: 754. doi: https://doi.org/10.3389/fendo.2018.00754.

Choi W, et al. Nature Commun 2018; 9(1): 4824. doi: https://doi.org/10.1038/s41467-018-07287-7.

Namkung J, et al. Diab Metab J 2018; 42(3): 233-243. doi: https://doi.org/10.4093/dmj.2017.0084

Yano JM, et al. Cell 2015; 161(2): 264-276. doi: https://doi.org/10.1016/j.cell.2015.02.047.

Ojeda-Rodriguez A, et al. Nutr Hospitalaria 2018; 35(2): 279-285.

Kulinskij VI, Kostjukovskaja AS. Lab Delo 1969; 7: 390-394.

Downloads

Published

2019-08-28

How to Cite

Parkhomenko, L. K., Strashok, L. A., & Khomenko, M. A. (2019). Influence of gastrointestinal hormones on the development of obesity and non-alcoholic fatty liver disease in children . Problems of Endocrine Pathology, 69(3), 128-135. https://doi.org/10.21856/j-PEP.2019.3.17